Fierce Pharma
SEPTEMBER 13, 2023
For decades, hundreds of oral decongestant products containing phenylephrine have been available in the United States over the counter. | For decades, hundreds of oral decongestant products containing phenylephrine have been available in the United States over the counter. But on Tuesday, an FDA advisory committee agreed by a 16-0 vote that the ingredient does not work.
MedCity News
SEPTEMBER 13, 2023
Healthcare IT companies raised $1 billion in venture capital in Q2 — down slightly from the $1.3 billion raised in Q1 but up significantly from the $451.3 million raised in Q4 2022. Unsurprisingly, a lot of these investments were made in companies offering generative AI products. Another key trend was increasing cash flow to remote patient monitoring startups, likely caused by expanded reimbursement for these services.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
SEPTEMBER 13, 2023
Merck & Co. was the first drugmaker to sue over the controversial Medicare price negotiation provisions in last year’s Inflation Reduction Act (IRA). | Merck & Co. was the first drugmaker to sue over the controversial Medicare price negotiation provisions in last year’s Inflation Reduction Act (IRA). But the New Jersey drug giant “lacks standing” to challenge the law in court, the Biden administration argued in a new filing.
MedCity News
SEPTEMBER 13, 2023
Solera Health recently launched a program that aims to help patients who are interested in GLP-1s gain access to lifestyle change support. It also provides educational materials on GLP-1s.
Advertiser: ZoomInfo
Marketing technology is essential for B2B marketers to stay competitive in a rapidly changing digital landscape — and with 53% of marketers experiencing legacy technology issues and limitations, they’re researching innovations to expand and refine their technology stacks. To help practitioners keep up with the rapidly evolving martech landscape, this special report will discuss: How practitioners are integrating technologies and systems to encourage information-sharing between departments and pr
Fierce Pharma
SEPTEMBER 13, 2023
While the FDA and the Centers for Disease Control and Prevention (CDC) have signed off on updated COVID vaccines for this season, Moderna is already reportedly preparing for lower demand for its sh | Moderna is speaking with its manufacturing partners to scale back production of its mRNA COVID vaccine to adapt to the endemic phase of the disease, Moderna’s president and R&D head, Stephen Hoge, said, Reuters reports.
Impetus Digital
SEPTEMBER 13, 2023
A version of this article was previously published in the Journal of mHealth. These days, clinical trials are in the news pretty much daily. Whether successful or not, they can impact not only the perception of a pharmaceutical company but also their stock prices. While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
SEPTEMBER 13, 2023
By leveraging technology and strategies used within the gig economy—and even tapping into the talent pool of gig workers themselves—healthcare organizations can address staffing shortages, retain and motivate more workers, and ultimately deliver better patient care.
Fierce Pharma
SEPTEMBER 13, 2023
After securing approval at the end of last year for a potential alternative to bladder removal in certain bladder cancer patients, Ferring Pharmaceuticals has given the gene therapy Adstiladrin to | While it scales up manufacturing, the company is rolling out its Adstiladrin through an early, focused program at certain clinics. The program will also be used for a real world evidence study.
European Pharmaceutical Review
SEPTEMBER 13, 2023
MSD Ireland’s new, state-of-the-art facility in Dunboyne, Co. Meath has opened. Additionally, the company has announced expansion of its Carlow site. In total, both projects represent an investment of over €1 billion. In total, both projects represent an investment of over €1 billion” MSD Carlow runs as filling site for the launch and commercial supply of vaccines , biologics, and small molecule drug products.
Fierce Pharma
SEPTEMBER 13, 2023
After Alnylam faced FDA doubts about its bid to expand RNA-silencing drug Onpattro into a rare heart disease called transthyretin amyloidosis cardiomyopathy (ATTR-CM), the company has picked up key | An FDA advisory committed voted in favor of Alnylam's bid to expand its RNA-silencing drug Onpattro into the rare heart disease called ATTR-CM. But comments at Wednesday’s panel suggest the drug could carry a disadvantage in its upcoming clash with Pfizer.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
MedCity News
SEPTEMBER 13, 2023
Bold, a Los Angeles-based company offering a healthy aging platform for older adults, closed a $17 million Series A funding round. The startup seeks to improve the health of Medicare Advantage beneficiaries through personalized exercise programs designed to prevent falls, decrease musculoskeletal pain and boost physical activity levels.
Fierce Pharma
SEPTEMBER 13, 2023
Less than four months after recommending Pfizer’s Vydura (rimegepant) to prevent m | Less than four months after recommending Pfizer’s Vydura (rimegepant) to prevent migraine headaches, England’s National Institute of Care and Health Excellence (NICE) has given it a thumbs up to treat them. With the nod, approximately 13,000 patients will have access to the first treatment approved in the U.K. for episodic (acute) migraine attacks.
MedCity News
SEPTEMBER 13, 2023
Pharmaceutical industry observers say CVS Health’s creation of Cordavis, a new biosimilar drugs company, is part of a strategy to make its move into this market as profitable as possible.
Fierce Pharma
SEPTEMBER 13, 2023
The evolution of clinical research has been dependent on the conversion of Healthcare Organizations (HCOs) to clinical research sites, along with the conversion of Healthcare Providers (HCPs) to Pr | Effective site enablement must address several factors, including protocol design, training, patient recruitment and enrollment, and more.
Advertiser: ZoomInfo
In times of economic uncertainty, account-based strategies are essential. According to several business analysts and practitioners, ABM is a necessity for creating more predictable revenue. Research shows that nearly three-quarters of marketers (74%) already have the resources needed to build successful ABM programs.
Pharmaceutical Technology
SEPTEMBER 13, 2023
The FDA is also reviewing a subcutaneous formulation of Takeda’s blockbuster drug for ulcerative colitis.
European Pharmaceutical Review
SEPTEMBER 13, 2023
Following a UK Medicines & Healthcare Products Regulatory Agency (MHRA) inspection, Rentschler Biopharma SE’s UK advanced therapy medicinal products (ATMP) facility has received a current good manufacturing practice (cGMP) Manufacturing Compliance Certificate. This means that the contract development and manufacturing organisation (CDMO)’s site in the Cell and Gene Therapy Catapult’s Manufacturing Innovation Centre in Stevenage, is compliant to produce adeno-associated virus (AAV) vectors fo
Pharmaceutical Technology
SEPTEMBER 13, 2023
Eli Lilly has had its therapy Mounjaro (tirzepatide) approved for patients in England with type 2 diabetes (T2D).
European Pharmaceutical Review
SEPTEMBER 13, 2023
As small and medium-sized enterprises (SMEs) often face unfair competition when doing business in Europe, through the (SME) Relief Communication, the European Commission (EC) has proposed new measures to provide short-term relief, boost long-term competitiveness, and improve equality in the business environment across the Single Market in Europe. This move will help address the needs of Europe’s SMEs in the current economic environment.
Advertiser: ZoomInfo
Shifting to an account-based marketing (ABM) strategy can be both exciting and challenging. Well-implemented ABM motions build engagement with high-value accounts and drive impactful campaigns that resonate with your audience. But where do you begin, and how do you progress from crawling to running? Watch now as Demand Gen experts delve into the essentials of each stage of the ABM process.
Pharmaceutical Commerce
SEPTEMBER 13, 2023
Further expansions of the pharmaceutical development and manufacturing services of ten23 are happening at the BASE and VIVA facilities to continue to support complex sterile product development, testing, and manufacturing.
PharmaTimes
SEPTEMBER 13, 2023
Theoria technologies aims to empower those affected by dementia - News - PharmaTimes
Clarify Health
SEPTEMBER 13, 2023
In September of 2023, marketing and strategy leaders from around the country gathered at the Society for Health Care Strategy & Market Development’s (SHSMD) annual conference in Chicago, IL. Clarify was excited to attend the conference and meet with these leaders to discuss health system growth strategies and provide real world insights during an interactive speaking session.
PharmaTimes
SEPTEMBER 13, 2023
Four research innovation teams are set to receive £500,000 each - News - PharmaTimes
Advertiser: ZoomInfo
One of the biggest challenges for any B2B marketer is understanding your prospects’ next move — who is most likely to buy and when. Without these insights, marketing campaigns can feel more like guesswork, with high investment and little return. We’re here to tell you there’s a better way. By tracking buyers’ digital footprints and online activity, such as website visits, product reviews, and spikes in content consumption, you can engage prospects with a message that really resonates.
Legacy MEDSearch
SEPTEMBER 13, 2023
Inspira Technologies OXY BHN Ltd. (Nasdaq: IINN , IINNW) (the “Company” or “Inspira Technologies”), a company aiming to bring a paradigm shift to acute respiratory care by empowering breathing without lungs, announced it had submitted its INSPIRA ART 100, a cardio-pulmonary bypass device, to the U.S. Food and Drug Administration (FDA) via the 510(k) pathway, with potential clearance expected during the first half of 2024.
PharmaTech
SEPTEMBER 13, 2023
Rentschler Biopharma’s ATMP business can now offer its full range of services for the clinical supply of AAV, including bioprocess and analytical development through to cGMP manufacturing at the Stevenage facility in the UK.
Contrarian Sales Techniques
SEPTEMBER 13, 2023
More Than Just a Sale You know that friend who’s always there when you need advice? Imagine if shopping felt like that - a helpful nudge in the right direction rather than someone pushing stuff on you. That's the magic some salespeople bring to the table. I've come to realize that the best salespeople don't really 'sell'. Instead, they're like your shopping buddy, guiding you to make the best choice.
PharmaTech
SEPTEMBER 13, 2023
Recipharm will provide analytical and process development capabilities to support toxicology studies, in addition to GLP manufacturing of lipid nanoparticles to capture the active pharmaceutical ingredient, an antigen peptide.
Advertiser: ZoomInfo
In this eBook, we’ll run through real-world examples that show how RevOps teams can benefit from modern solutions for the access, management, and activation of their GTM data. Whether you need to improve lead response times, boost adoption of core tools, improve lead qualification, or target and automate your GTM motions, you’ll find examples of how revenue teams are solving some of the toughest problems in modern business.
PharmExec
SEPTEMBER 13, 2023
As the industry expands on areas of women’s health with large unmet medical needs, one biotech company is targeting local, vaginal inflammation, specifically for women undergoing IVF and to address other fertility- and reproductive tract-associated health conditions.
PharmaTech
SEPTEMBER 13, 2023
Seagen will be responsible for conjugating these degraders to antibodies to make DACs and advancing these DAC drug candidates through preclinical and clinical development and commercialization.
Pharmaceutical Technology
SEPTEMBER 13, 2023
Currently, NSCLC patients with EGFR exon 19 deletions or L858R substitution face limited therapeutic options after seeing disease progression post-front-line treatment.
Copyright Clearance Center
SEPTEMBER 13, 2023
The post Frontiers Adopts CCC Ringgold Identify Database appeared first on Copyright Clearance Center.
Advertiser: ZoomInfo
Consolidating your tech stack is an effective cost-saving measure that drives GTM efficiency and adds value to your enterprise. With a cohesive, integrated tech stack, your revenue teams can deliver an excellent customer experience that sets you up to win faster than your competitors.
Expert insights. Personalized for you.
313 
Let's personalize your content